临床试验药物安全性

关键字：类型：

下载页码(大于0,小于852)：

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

临床试验药物安全性 1506条(本栏目收费,不能显示细节,电话13136136841)

Advisory Committee,meetings,800,801 801

Afatinib,27 27

Airway hyper-responsiveness (AHR),580 580

Aliskirin for hypertension,167,168 168

Allin study,396 396

Allocation blinding comparison,137,139 139

importance,137,138 138

enrollment over time,142,143 143

manual techniques coin toss,142 142

sealed envelopes,140,142 142

overview,137,139 139

Alzheimer’s disease randomization code breaking example,145 145

Amendments Clinical Study Protocol,66 68 66 68

Amino acids characteristics and pharmacological importance,8,10 10

4-Aminopyridine,434 434

Aminotransferases,491 491

Anatomical Therapeutic Chemical(ATC) system,693 693

Anemia,62,62,68,109,341,348,350 350

Animal models,11,21 21

Animal Rule,19,20 20

developing an accepted animal model for a disease,15,16 16

disease mechanisms,13,15 15

FDA Form 483 483

warning letters,examples of,18,19 19

FDA regulations and,13 13

FDA’s decision-making process in evaluating raxibacumab,20,21 21

GLP 16,18 18

of human diseases,11,13 13

validation of,16 16

FDA’s decision-making process in,707 707

最新招商产品更多>>

浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　

浙公网安备:330683240604819103159
　医药代理商群１：

医药代理商群２：

医药代理商群３：